LabVantage Solutions has launched LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform designed to expand the capabilities of its laboratory information management system (LIMS). The platform integrates advanced AI and automation into the LabVantage LIMS environment to help laboratories improve efficiency, reduce errors, and gain deeper insight from laboratory data.
LabVantage developed the platform to support growing demand for intelligent, automated laboratory environments across sectors including pharmaceutical and biotechnology, food and beverage, oil and gas, and forensics. LabVantage CORTEX provides an AI-driven ecosystem that helps laboratories strengthen operational efficiency while accelerating research and development efforts.
The launch comes at a time when laboratories increasingly explore AI adoption. A recent survey by Pistoia Alliance in partnership with Lab of the Future found that more than 75% of laboratories plan to implement artificial intelligence or machine learning technologies within the next two years. LabVantage CORTEX expands the capabilities of LabVantage LIMS and supports more adaptive and self-optimizing laboratory environments.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
“LabVantage CORTEX is more than just an upgrade; it is a fundamental reimagining of how laboratories interact with their data and processes,” said Gary Stimson, principal architect and head of AI technologies at LabVantage Solutions. “LabVantage CORTEX positions our customers at the forefront of laboratory innovation, enabling autonomous workflows, predictive quality control, and seamless regulatory compliance.”
Platform Designed for AI and Cloud-Based Laboratory Automation
LabVantage CORTEX combines AI-driven capabilities with the established LabVantage LIMS environment. The platform operates as a multi-tenant, cloud-native system where autonomous AI agents manage complex laboratory tasks within the LIMS framework.
This architecture enables laboratories to adopt new AI capabilities without requiring a full system replacement. The cloud-native Software-as-a-Service (SaaS) platform also provides an upgrade path for existing LabVantage customers.
LabVantage CORTEX integrates with Internet of Things (IoT) devices and digital twin technologies. These integrations support real-time environmental monitoring, predictive maintenance, and proactive laboratory management. The company designed these capabilities to help laboratories maintain agility and scale operations as future requirements evolve.
Mikael Hagstroem, chief executive officer of LabVantage Solutions, highlighted the company’s broader vision for autonomous laboratories enabled by AI technologies.
“LabVantage is committed to steadily improving LabVantage CORTEX with semantic capabilities, more agentic AI features, and seamless integration with new technologies. Our aim is to help customers speed up discovery and reach the market faster while supporting scientific advancement and operational efficiency.”
AI Capabilities Target Common Laboratory Challenges
LabVantage CORTEX introduces several AI-enabled functions designed to address routine operational challenges across laboratory workflows.
These capabilities include:
- Worksheet assistance that supports data entry and analysis
- Sample management assistance that simplifies repetitive tasks and optimizes laboratory resources
- Stability study assistance that monitors product trends and creates protocols
- Process simplification tools that free time for laboratory personnel
- Automated compliance monitoring aligned with FDA, EMA, and ISO standards
Together, these capabilities aim to reduce manual work, limit errors, streamline laboratory processes, and generate actionable insights across the laboratory lifecycle.
LabVantage leaders will discuss the platform at Pittcon 2026, held March 7–11 in San Antonio, Texas, at the Henry B. González Convention Center. The company will exhibit at booth #2837.
This article is based on a press release issued by LabVantage.
